[February 07, 2014] |
|
Supernus at Citibank and RBC Global Healthcare Conferences in February
ROCKVILLE, Md. --(Business Wire)--
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty
pharmaceutical company, today announced that the Company's management
will be hosting investor meetings during Citi's 2014 Global Healthcare
Conference.
Date: Tuesday, February 25 Place: The Hilton New York Hotel
Investors interested in arranging a meeting during this conference
should contact their Citi representative.
Supernus also announced that management will providea business update
on the Company at the 2014 RBC Capital Markets Global Healthcare
Conference.
Date: Wednesday, February 26 Presentation Time: 9:00am ET Place:
The New York Palace, New York, NY
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company
focused on developing and commercializing products for the treatment of
central nervous system, or CNS, diseases. The Company has two marketed
products for epilepsy, Oxtellar XR® (extended-release oxcarbazepine) and
Trokendi XR™ (extended-release topiramate). The Company is also
developing several product candidates in psychiatry to address large
market opportunities in ADHD, including ADHD patients with impulsive
aggression. These product candidates include SPN-810 for impulsive
aggression in ADHD and SPN-812 for ADHD.
[ Back To TMCnet.com's Homepage ]
|